Simmunome Inc.-preview

Simmunome

Simmunome Inc.

Private

Montreal, QuebecHealthcare & Life Scienceshttps://simmunome.com

Last Round

Accelerator

Jun 20, 2025

Total Funding Raised

$1.78M

Company Overview

Simmunome Inc. is a biotechnology company that provides an AI-driven SaaS platform for disease simulations to predict clinical trial outcomes and improve drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Precision Medicine, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

disease simulationin silico drug developmentdrug discoveryclinical trial predictioncomputational biologydrug discovery SaaSbiological digital twinpatient stratificationmechanistic modelingpredictive biomarkerstarget validationno-code platformmedical AIprecision medicineoncologyneurodegenerative diseasedrug target discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Simmunome Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Simmunome Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Jun 20, 2025
Grant	Feb 28, 2025
Pre Seed	Sep 18, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Nardin Nakhla

Co-founder CTO

Founding Team

Simmunome Inc. Investors

Notable investors and investment history

Investor	Rounds
Génome Québec	Grant
Sandpiper Ventures	Pre Seed
BKR Capital	Pre Seed
Consortium Québécois sur la découverte du médicament	Accelerator
Merck Global Health Innovation Fund	Accelerator
ACET Capital	Pre Seed
Theodorus	Pre Seed

View all Investors

Simmunome Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Simmunome Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Simmunome Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal, Quebec

Employee Range8

Year Founded2019

Last FundingJun 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.